The Acute Rise in Plasma Fibrinogen Concentration with Exercise Is Influenced by the G-453-A Polymorphism of the β-Fibrinogen Gene

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 3, 1996, Pages 386-391

  Montgomery, Hugh E ^a,f   Clarkson, Peter ^b   Nwose, O M ^c   Mikailidis, D P ^c   Jagroop, I A ^c   Dollery, Clare ^a   Moult, James ^a   Benhizia, Ferdaous ^a   Deanfield, John ^a   Jubb, Mick ^d   World, Michael ^e   McEwan, Jean R ^a   Winder, Anthony ^c   Humphries, Stephen ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d Army Training Regiment Bassingbourn   (United Kingdom)

^e Army Medical College   (United Kingdom)

^f UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Exercise; Fibrinogen; G A polymorphism; Training

Indexed keywords

FIBRINOGEN; FIBRINOGEN B BETA CHAIN; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ADULT; ALLELE; ARMY; ARTICLE; CONTROLLED STUDY; EXERCISE; FITNESS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; EXERCISE; FIBRINOGEN; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC;

EID: 0029978105     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.3.386     Document Type: Article

References (74)

1. Smith EB. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis. Clin Haematol. 1986;15:355-370.
2. Duguid JB. Thrombosis as a factor in the pathogenesis of aortic atherosclerosis. J Pathol Bacterial. 1948;58:207-212.
3. Velican D, Velican C. Study of fibrous plaques occurring in the coronary arteries of children. Atherosclerosis. 1979;33:201-215.
4. Di Minno G, Mancini M. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis. 1990;10:1-7.
5. Watanabe K, Tanaka K. Influence of fibrin, fibrinogen and fibrinogen degradation products on cultured endothelial cells. Atherosclerosis. 1983;48:57-70.
6. Ishida T, Tanaka K. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture. Atherosclerosis. 1982;44:161-174.
7. Shah P, Chander R, Daly K. Plasma fibrinogen level and other risk factor profile: association with coronary artery disease. Br Heart J. 1995;71:25. Abstract.
8. Meade TW, North WR, Chakrabarti R, Stirling Y, Haines AP, Thompson SG, Brozovic M. Hemostatic function and cardiovascular death: early results of the Northwick Park Heart study. Lancet. 1980;1:1050-1054.
9. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, Haines AP, Stirling Y, Imeson JD, Thompson SG. Hemostatic function and ischemic heart disease: principal results of the Northwick Park Heart study. Lancet. 1986;2:533-537.
10. Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. Circulation. 1991;83:836-844.
11. Stone MC, Thorp JM. Plasma fibrinogen: a major coronary risk factor. J R Coll Gen Pract. 1985;35:565-569.
12. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501-505.
13. Kannel WB, Wolf PA, Catelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: the Framingham study. JAMA. 1987;258:1183-1186.
14. Qizilbash N, Jones L, Warlow C, Mann J. Fibrinogen and lipid concentrations as risk factors for transient ischemic attacks and minor ischemic strokes. BMJ. 1991;303:605-609.
15. Resch K, Ernst E, Matrai A, Paulsen H. Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors. Ann Intern Med. 1992;117:371-375.
16. Ernst E. Plasma fibrinogen: an independent cardiovascular risk factor. J Intern Med. 1990;227:365-372.
17. Slattery ML, Jacobs DR. Physical fitness and cardiovascular disease mortality. Am J Epidemiol. 1988;127:571-580.
18. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol. 1990;132:612-628.
19. Slattery ML, Jacobs DR, Nichaman MZ. Leisure time physical activity and coronary heart disease: the US Railroad study. Circulation. 1989;79:304-311.
20. Morris JN, Everitt MG, Pollard R, Chave SPW. Vigorous exercise in leisure-time: protection against coronary heart disease. Lancet. 1980;2:1207.
21. Simonsick EM, Lafferty ME, Phillips CL, Mendes de Leon CF, Kasl SV, Seeman TE, Fillenbaum G, Hebert P, Lemke JH. Risk due to inactivity in physically capable older adults. Am J Public Health. 1993;83:1443-1450.
22. Morris JN, Heady JA, Raffle PAB, Roberts CG, Parks JW. Coronary heart disease and physical activity at work. Lancet. 1953;2:1111-1120.
23. Fox SM III, Naughton JP, Gorman PA. Physical activity and cardiovascular health, I: potential for prevention of coronary heart disease and possible mechanisms. Mod Concepts Cardiovasc Dis. 1972;41:17-20.
24. Shinton R, Sagar G. Lifelong exercise and stroke. BMJ. 1993;307:231-234.
25. Wannamethee G, Shaper AG. Physical activity and stroke in British middle aged men. BMJ. 1992;304:597-601.
26. Housley E, Leng GC, Donnan PT, Fowkes FGR. Physical activity and risk of peripheral arterial disease in the general population: Edinburgh Artery Study. J Epidemiol Community Health. 1993;47:475-480.
27. May GS, Eberlein KT, Furbery CD, Passamani ER, De Mets DL. Secondary prevention after myocardial infarction: a review of long-term trials. Prog Cardiovasc Dis. 1982;23:331-352.
28. O'Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS, Hennekens CH. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation. 1989;80:234-244.
29. Paffenbarger RS, Hyde RT, Wing AL, Hsieh C. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med. 1986;314:605-613.
30. Willich SN, Lewis M, Lowel H, Arntz H-R, Schubert F, Schroder R. Physical exertion as a trigger of acute myocardial infarction. N Engl J Med. 1993;329:1684-1690.
31. Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Mullers JE. Triggering of acute myocardial infarction by heavy physical exertion: protection against triggering by regular exertion. N Engl J Med. 1993;329:1678-1683.
32. Ernst E. Regular exercise reduces fibrinogen levels: a review of longitudinal studies. Br J Sports Med. 1993;27:175-176.
33. Fendler K, Lissak K, Romhanyi M, Osz E, Szucs R, Kovacs GL. Adaptive processes in child and adolescent swimmers: blood coagulation and viscosity. Acta PhysiolAcad Sci Hung. 1977;49:17-26.
34. Stratton JR, Chandler WL, Schwartz RS, Cerqueira MD, Levy WC, Kahn SE, Larson VG, Cain KC, Beard JC, Abrass IB. Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation. 1991;83:1692-1697.
35. Arai M, Yorifuji H, Ikematsu S, Nagasawa H, Fujimaki M, Fukutake K, Katsumura T, Ishii T, Iwane H. Influences of strenuous exercise (triathlon) on blood coagulation and fibrinolytic system. Thromb Res. 1990;57:465-471.
36. Hansen J, Wilsgard L, Olsen JO, Osterud B. Formation and persistence of procoagulant and fibrinolytic activities in circulation after strenuous physical exercise. Thromb Haemost. 1990;64:385-389.
37. Keber D, Stegnar M, Keber I, Accetto B. Influence of moderate and strenuous daily physical activity on fibrinolytic activity of blood: possibility of plasminogen activator stores depletion. Thromb Haemost. 1979;41:745-755.
38. Moxley RT, Brakman P, Astrup T. Resting levels of fibrinolysis in blood in inactive and exercising men. J Appl Physiol. 1970;28:549-552.
39. Dufaux B, Order U, Hollman W. Can exercise induce an effective fibrinolysis? Thromb Res. 1984;36:37-43.
40. Scarabin P-Y, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction: the ECTIM study. Arterioscler Thromb. 1993;13:886-891.
41. Wilkes HC, Kelleher C, Meade TW. Smoking and plasma fibrinogen. Lancet. 1988;1:307-308.
42. Yarnell JW, Sweetnam PM, Rogers S, Elwood PC, Bainton D, Baker IA, Eastham R, O'Brien JR, Etherington MD. Some long-term effects of smoking on the hemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys. J Clin Pathol. 1987;40:909-913.
43. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham study. Am Heart J. 1987;113:1006-1010.
44. Heinrich J, Funke H, Rust S, Schulte H, Schonfeld R, Kohler E, Assmann G. Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb Res. 1995;77:209-215.
45. Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW. Role of genetic variation at fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet. 1987;1:1452-1455.
46. Roy SN, Mukhopadhyay G, Redman CM. Regulation of fibrinogen assembly: transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem. 1990;265:6389-6393.
47. Dalmon J, Laurent M, Courtois G. The human beta fibrinogen promotor contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol Cell Biol. 1993;13:1183-1193.
48. Reed T, Tracy RP, Fabsitz RR. Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI Twin Study. Clin Genet. 1994;45:71-77.
49. Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promotor region of the β fibrinogen gene is associated with plasma fibrinogen levels in smokers and nonsmokers. Thromb Haemost. 1991;65:487-490.
50. Green F, Hamsten A, Blomback M, Humphries S. The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost. 1993;70:915-920.
51. Humphries SE, Ye S, Talmud P, Bara L, Wilhelmsen L, Tiret L. European Atherosclerosis Research Study: genotype at the fibrinogen locus (G455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe: evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol. 1995;15:96-104.
52. Rankinen T, Rauramaa R, Vaisanen S, Penttila IM, Uusitupa M. Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors. Thromb Haemost. 1994;71:180-183.
53. Lee AJ, Smith WCS, Lowe GDO, Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J Clin Epidemiol. 1990;9:913-919.
54. Rosengren A, Wilhelmsen L, Welin L, Tsipogianni A, Teger-Nilsson AC, Wedel H. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged man. BMJ. 1990;300:634-638.
55. Morris JN, Clayton DG, Everitt MG, Semmence AM, Burgess EH. Exercise in leisure time: coronary attack and death rate. Br Heart J. 1990;63:325-334.
56. Rankinen T, Rauramaa R, Vaisanen S, Penttila I, Saarikoski S, Tuomilehto J, Nissinen A. Inverse relationship between physical activity and plasma fibrinogen in postmenopausal women. Atherosclerosis. 1993;102:181-186.
57. Speiser W, Langer W, Pschaick A, Selmayr E, Ibe B, Nowacki PE, Muller-Berghaus G. Increased blood fibrinolytic activity after physical exercise: comparative study in individuals with different sporting activities and in patients after myocardial infarction taking part in a rehabilitation sports program. Thromb Res. 1988;51:543-555.
58. Ernst EEW, Matrai A. Intermittent claudication, exercise, and blood rheology. Circulation. 1987;76:1110-1114.
59. Wosornu D, Allardyce W, Ballantyne D, Tansey P. Influence of power and aerobic exercise training on hemostatic factors after coronary artery surgery. Br Heart J. 1992;68:181-186.
60. Ernst E, Schmid M. Regular aerobic exercise lowers fibrinogen levels: results of a pilot study. Arch Phys Med Rehabil. 1993;3:196-198.
61. Green F, Humphries S. Control of plasma fibrinogen levels. Ballieres Clin Haematol. 1989;2:945-959.
62. Thompson SG, Kienast J, Pyke SDM, Haverkate F, Van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
63. Haines AP, Howarth D, North WRS, Goldenberg E, Stirling Y, Meade TW, Raftery EB, Craig MWM. Hemostatic variables and outcome of acute myocardial infarction. Thromb Haemost. 1983;50:800-803.
64. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993;118:956-963.
65. Thompson PD, Cullinane EM, Sady SP, Flynn MM, Bernier DMN, Kantor MA, Sartitelli AL, Herbert PN. Modest changes in high- density lipoprotein concentration and metabolism with prolonged exercise training. Circulation. 1988;78:25-34.
66. Stratton JR, Levy WC, Cerqueira MD, Schwartz RS, Abrass IB. Cardiovascular responses to exercise: effect of aging and exercise training in healthy men. Circulation. 1994;89:1648-1655.
67. Behague I, Poirier O, Nicaud V, Evans A, Arveiller D, Luc G, Cambou J-P, Scarabin P-Y, Bara L, Green F, Cambien F. Association between fibrinogen gene polymorphisms, plasma fibrinogen, and coronary heart disease: the ECTIM study. Circulation. 1995. In press.
68. Humphries SE, Green FR, Henney AM, Talmud PJ. DNA polymorphisms: the variability gene concept and the risk of coronary heart disease. In: Beam AG, ed. Genetics of Coronary Heart Disease. Oslo, Norway: Institute of Medical Genetics, University of Oslo; 1992:123-142.
69. Thomas A, Lamlum H, Humphries S, Green F. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (Hae III), C/T-148 (HindIII/Alu I), T/G+1689 (Ava II), and Bcl1 (beta-fibrinogen) and TaqI (alpha-fibrinogen), and their detection by PCR. Hum Mutat. 1994;3:79-81.
70. Letcher RL, Chien S, Pickering TG, Sealey JE, Laragh JH. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects: role of fibrinogen concentration. Am J Med. 1981;70:1195-1202.
71. Ernst E, Matrai A, Scholzl C, Magyarosy I. Dose-effect relationship between smoking and blood rheology. Br J Haematol. 1987;65:485-487.
72. Powell JT, Sian M, Wiseman S, Grennhalgh RM. Fibrinogen and carboxyhaemoglobin in peripheral arterial disease. Lancet. 1988;1:121. Letter.
73. Streiff M, Bell WR. Exercise and hemostasis in humans. Semin Hematol. 1994;31:155-165.
74. Stout RW, Crawford V. Seasonal variations in fibrinogen concentrations among elderly people. Lancet. 1991;338:9-13.